C Difficile

9585 bookmarks
Newest
Discrimination between hypervirulent and non-hypervirulent ribotypes of Clostridioides difficile by MALDI-TOF mass spectrometry and machine learning - PubMed
Discrimination between hypervirulent and non-hypervirulent ribotypes of Clostridioides difficile by MALDI-TOF mass spectrometry and machine learning - PubMed
Hypervirulent ribotypes (HVRTs) of Clostridioides difficile such as ribotype (RT) 027 are epidemiologically important. This study evaluated whether MALDI-TOF can distinguish between strains of HVRTs and non-HVRTs commonly found in Europe. Obtained spectra of clinical C. difficile isolates (training …
·pubmed.ncbi.nlm.nih.gov·
Discrimination between hypervirulent and non-hypervirulent ribotypes of Clostridioides difficile by MALDI-TOF mass spectrometry and machine learning - PubMed
The surprising origin of a deadly hospital infection
The surprising origin of a deadly hospital infection
Surprising findings from a new study suggest that the burden of C. diff infection may be less a matter of hospital transmission and more a result of characteristics associated with the patients themselves.
·news.google.com·
The surprising origin of a deadly hospital infection
Effectiveness of ultraviolet-C disinfection systems for reduction of multi-drug resistant organism infections in healthcare settings: A systematic review and meta-analysis - PubMed
Effectiveness of ultraviolet-C disinfection systems for reduction of multi-drug resistant organism infections in healthcare settings: A systematic review and meta-analysis - PubMed
This study aimed to summarise the findings of the studies assessing the effectiveness of ultraviolet C (UV-C) room disinfection in reducing the incidence rate of healthcare-associated multi-drug-resistant organism (MDRO) infections. A systematic screening was conducted using PubMed, EMBASE, and Scop …
·pubmed.ncbi.nlm.nih.gov·
Effectiveness of ultraviolet-C disinfection systems for reduction of multi-drug resistant organism infections in healthcare settings: A systematic review and meta-analysis - PubMed
Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficile in an intensive care unit - PubMed
Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficile in an intensive care unit - PubMed
Despite enhanced infection prevention efforts, Clostridioides difficile remains the leading cause of healthcare-associated infections in the United States. Current prevention strategies are limited by their failure to account for patients who carry C. difficile asymptomatically, who may act as hidde …
·pubmed.ncbi.nlm.nih.gov·
Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficile in an intensive care unit - PubMed
Novel ribotype/sequence type associations and diverse CRISPR-Cas systems in environmental Clostridioides difficile strains from Northern Iraq - PubMed
Novel ribotype/sequence type associations and diverse CRISPR-Cas systems in environmental Clostridioides difficile strains from Northern Iraq - PubMed
The environment is a natural reservoir of Clostridioides difficile and here, we aimed to isolate the pathogen from seven locations in Northern Iraq. Four of the sites yielded thirty-one isolates (ten from soils, twenty-one from sediments) which together represent ribotypes 001 (five), 010 (five), 01 …
·pubmed.ncbi.nlm.nih.gov·
Novel ribotype/sequence type associations and diverse CRISPR-Cas systems in environmental Clostridioides difficile strains from Northern Iraq - PubMed
Protocol for a double-blinded randomised controlled trial to assess the effect of faecal microbiota transplantations on thyroid reserve in patients with subclinical autoimmune hypothyroidism in the Netherlands: the IMITHOT trial - PubMed
Protocol for a double-blinded randomised controlled trial to assess the effect of faecal microbiota transplantations on thyroid reserve in patients with subclinical autoimmune hypothyroidism in the Netherlands: the IMITHOT trial - PubMed
NL7931.
·pubmed.ncbi.nlm.nih.gov·
Protocol for a double-blinded randomised controlled trial to assess the effect of faecal microbiota transplantations on thyroid reserve in patients with subclinical autoimmune hypothyroidism in the Netherlands: the IMITHOT trial - PubMed
Uncommon Presentation of Clostridioides difficile in the Small Bowel: A Case Report and Review of Literature - PubMed
Uncommon Presentation of Clostridioides difficile in the Small Bowel: A Case Report and Review of Literature - PubMed
Clostridioides difficile infection (CDI) is a prevalent source of hospital-acquired diarrhea. The most common presentation of CDI is colitis. In cases of fulminant colitis/toxic megacolon, a colectomy and end ileostomy are part of the treatment plan. There is evidence to suggest that it may b …
·pubmed.ncbi.nlm.nih.gov·
Uncommon Presentation of Clostridioides difficile in the Small Bowel: A Case Report and Review of Literature - PubMed
Reducing antimicrobial overuse through targeted therapy for patients with community-acquired pneumonia: a study protocol for a cluster-randomized factorial controlled trial (CARE-CAP) - PubMed
Reducing antimicrobial overuse through targeted therapy for patients with community-acquired pneumonia: a study protocol for a cluster-randomized factorial controlled trial (CARE-CAP) - PubMed
ClinicalTrials.gov NCT05568654 . Registered on October 4, 2022.
·pubmed.ncbi.nlm.nih.gov·
Reducing antimicrobial overuse through targeted therapy for patients with community-acquired pneumonia: a study protocol for a cluster-randomized factorial controlled trial (CARE-CAP) - PubMed
Discovery of 1,2-diaryl-3-oxopyrazolidin-4-carboxamides as a new class of MurA enzyme inhibitors and characterization of their antibacterial activity - PubMed
Discovery of 1,2-diaryl-3-oxopyrazolidin-4-carboxamides as a new class of MurA enzyme inhibitors and characterization of their antibacterial activity - PubMed
The cytoplasmic steps of peptidoglycan synthesis represent an important targeted pathway for development of new antibiotics. Herein, we report the synthesis of novel 3-oxopyrazolidin-4-carboxamide derivatives with variable amide side chains as potential antibacterial agents targeting MurA enzyme, th …
·pubmed.ncbi.nlm.nih.gov·
Discovery of 1,2-diaryl-3-oxopyrazolidin-4-carboxamides as a new class of MurA enzyme inhibitors and characterization of their antibacterial activity - PubMed
Clostridioides (Clostridium) difficile: A silent nosocomial pathogen - PubMed
Clostridioides (Clostridium) difficile: A silent nosocomial pathogen - PubMed
Clostridioides difficile (C. difficile) infection is still a threat to many healthcare settings worldwide. Clostridioides difficile epidemiology has changed over the last 20 years, largely due to the emergence of hypervirulent and antimicrobial-resistant C. difficile strains. Th …
·pubmed.ncbi.nlm.nih.gov·
Clostridioides (Clostridium) difficile: A silent nosocomial pathogen - PubMed
Screening for Asymptomatic Clostridioides difficile Carriage Among Hospitalized Patients: A Narrative Review - PubMed
Screening for Asymptomatic Clostridioides difficile Carriage Among Hospitalized Patients: A Narrative Review - PubMed
Clostridioides difficile infection (CDI) has become the most common healthcare-associated infection in the United States, with considerable morbidity, mortality, and healthcare costs. Assessing new preventive strategies is vital. We present a literature review of studies evaluating a strategy of scr …
·pubmed.ncbi.nlm.nih.gov·
Screening for Asymptomatic Clostridioides difficile Carriage Among Hospitalized Patients: A Narrative Review - PubMed
Syndromic Panel Testing Among Patients With Infectious Diarrhea: The Challenge of Interpreting Clostridioides difficile Positivity on a Multiplex Molecular Panel - PubMed
Syndromic Panel Testing Among Patients With Infectious Diarrhea: The Challenge of Interpreting Clostridioides difficile Positivity on a Multiplex Molecular Panel - PubMed
Patients with a positive CD PCR were likely to receive treatment regardless of PTP or CD toxin results. We recommend that CD positivity on GIPCR be interpreted with caution, particularly in the setting of a low PTP.
·pubmed.ncbi.nlm.nih.gov·
Syndromic Panel Testing Among Patients With Infectious Diarrhea: The Challenge of Interpreting Clostridioides difficile Positivity on a Multiplex Molecular Panel - PubMed
Budesonide, an anti-inflammatory drug, exacerbate clostridioides difficile colitis in mice - PubMed
Budesonide, an anti-inflammatory drug, exacerbate clostridioides difficile colitis in mice - PubMed
Anti-inflammatory drugs including corticosteroid therapy may worsen the incidence and severity of CDI in this mouse model. These studies may have important clinical implications for understanding the role of anti-inflammatory/ corticosteroid therapy in CDI and inflammatory bowel disease management.
·pubmed.ncbi.nlm.nih.gov·
Budesonide, an anti-inflammatory drug, exacerbate clostridioides difficile colitis in mice - PubMed
Majority of Patients with C Diff Willing to Use Rectally Administered Treatment
Majority of Patients with C Diff Willing to Use Rectally Administered Treatment
Survey results showed patients with a history of live biotherapeutic product therapy preferred rectally administered treatment while patients who had not received live biotherapeutic product therapy would be willing to consider it.
·news.google.com·
Majority of Patients with C Diff Willing to Use Rectally Administered Treatment
Evaluation of the effectiveness and safety of oral vancomycin versus placebo in the prevention of recurrence of Clostridioides difficile infection in patients under systemic antibiotic therapy: a phase III, randomised, double-blind clinical trial - PubMed
Evaluation of the effectiveness and safety of oral vancomycin versus placebo in the prevention of recurrence of Clostridioides difficile infection in patients under systemic antibiotic therapy: a phase III, randomised, double-blind clinical trial - PubMed
NCT05320068.
·pubmed.ncbi.nlm.nih.gov·
Evaluation of the effectiveness and safety of oral vancomycin versus placebo in the prevention of recurrence of Clostridioides difficile infection in patients under systemic antibiotic therapy: a phase III, randomised, double-blind clinical trial - PubMed